Piramal Enterprises Limited

Ranjit Shahani, the former chief of Novartis India Ltd. and the face of the Swiss multinational in the country for over a decade, including during the tumultuous Glivec (imatinib mesylate) patent ba

Way back in March 1996, Swiss pharmaceutical companies Ciba-Geigy and Sandoz. decided to merge and form what was then the world’s biggest life sciences combine christened Novartis . The India merge

C-suite remuneration across over a dozen pharma companies in India, moved upwards in 2022-23, save a few exceptions, with top-level compensation at local firms continuing to, by and large, dwarf compa

Glenmark Pharmaceuticals Limited has divested its active pharmaceutical ingredients (API) business to the diversified Indian group Nirma Limited for INR56.51bn ($681m), ending long-running speculatio